» Articles » PMID: 25848763

Multi-lineage Differentiation of Human Umbilical Cord Wharton's Jelly Mesenchymal Stromal Cells Mediates Changes in the Expression Profile of Stemness Markers

Overview
Journal PLoS One
Date 2015 Apr 8
PMID 25848763
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Wharton's Jelly- derived Mesenchymal stem cells (WJ-MSCs) have gained interest as an alternative source of stem cells for regenerative medicine because of their potential for self-renewal, differentiation and unique immunomodulatory properties. Although many studies have characterized various WJ-MSCs biologically, the expression profiles of the commonly used stemness markers have not yet been addressed. In this study, WJ-MSCs were isolated and characterized for stemness and surface markers expression. Flow cytometry, immunofluorescence and qRT-PCR analysis revealed predominant expression of CD29, CD44, CD73, CD90, CD105 and CD166 in WJ-MSCs, while the hematopoietic and endothelial markers were absent. Differential expression of CD 29, CD90, CD105 and CD166 following adipogenic, osteogenic and chondrogenic induction was observed. Furthermore, our results demonstrated a reduction in CD44 and CD73 expressions in response to the tri-lineage differentiation induction, suggesting that they can be used as reliable stemness markers, since their expression was associated with undifferentiated WJ-MSCs only.

Citing Articles

Comparing the growth kinetics and characteristics of Wharton's jelly derived mesenchymal stem cells expanded using different culture mediums.

Hassan M, Yazid M, Yunus M, Lokanathan Y, Ng M, Idrus R Cytotechnology. 2024; 77(1):24.

PMID: 39711971 PMC: 11659549. DOI: 10.1007/s10616-024-00682-7.


Efficacy of stem cells versus microvesicles in ameliorating chronic renal injury in rats (histological and biochemical study).

Mohammed M, Abdelrahman S, El-Shal A, Abdelrahman A, Hamdy M, Sarhan W Sci Rep. 2024; 14(1):16589.

PMID: 39025899 PMC: 11258134. DOI: 10.1038/s41598-024-66299-0.


Differential gene expression of Wharton's jelly-derived mesenchymal cells mediated by graphene oxide in basal and osteo-induced media.

Hiew V, Teoh P Mol Biol Rep. 2024; 51(1):383.

PMID: 38433142 DOI: 10.1007/s11033-024-09324-9.


Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes.

Madhoun A, Koti L, Carrio N, Atari M, Al-Mulla F Stem Cells Transl Med. 2023; 13(2):101-106.

PMID: 37950618 PMC: 10872683. DOI: 10.1093/stcltm/szad077.


Wharton's jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications.

Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Madhoun A Front Cell Dev Biol. 2023; 11:1211217.

PMID: 37440921 PMC: 10333601. DOI: 10.3389/fcell.2023.1211217.


References
1.
Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X . Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med. 2011; 5(1):94-100. DOI: 10.1007/s11684-011-0116-z. View

2.
Brunner M, Millon-Fremillon A, Chevalier G, Nakchbandi I, Mosher D, Block M . Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition. J Cell Biol. 2011; 194(2):307-22. PMC: 3144405. DOI: 10.1083/jcb.201007108. View

3.
Seshareddy K, Troyer D, Weiss M . Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol. 2008; 86:101-19. DOI: 10.1016/S0091-679X(08)00006-X. View

4.
Dmitrieva R, Minullina I, Bilibina A, Tarasova O, Anisimov S, Zaritskey A . Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle. 2011; 11(2):377-83. DOI: 10.4161/cc.11.2.18858. View

5.
Sarugaser R, Hanoun L, Keating A, Stanford W, Davies J . Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One. 2009; 4(8):e6498. PMC: 2714967. DOI: 10.1371/journal.pone.0006498. View